
AMN Stock Forecast & Price Target
AMN Analyst Ratings
Bulls say
AMN Healthcare Services is supported by a clear recovery in its core Nurse and Allied segment, where travel nurse volume rose 21% y/y and 3Q revenue increased 27% y/y to $460M as total revenue climbed 13% y/y to $717M. The company also showed strong operating leverage, with adjusted EBITDA of $94M versus $44M consensus and adjusted EPS up 199% y/y to $1.16, while lower-cost Language Services and improving productivity should help offset pricing pressure and support margin recovery. With Kaiser representing 22% of '25 revenue and management saying it is “very well positioned” for the contract renewal process, plus expectations for stabilization over the next 12 months and normalized 4-6% revenue growth, the fundamental outlook remains constructive.
Bears say
AMN Healthcare Services is facing a deteriorating fundamental backdrop as demand for contract labor continues to normalize after the COVID-related peak, with organic segment revenue up 9% Y/Y in 2024 but down 4% in 2025 and expected to fall another 4% in 2026. Management also faces pressure from shrinking days filled, which is modeled to drop 8% in 2025 and 9% in 2026, while language services revenue fell 1% in 2025 and 8% in Q1 amid competitive pricing pressure. With nearly $1B in debt, VMS revenue down at a (35%) CAGR from 2022 to 2025, and risks from nurse recruitment, retention, regulation, and customer concentration, earnings quality and balance-sheet flexibility appear increasingly strained.
This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.
AMN Analyst Forecast & Price Prediction
Start investing in AMN
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About AMN Healthcare Services (AMN) Forecast
AMN Analyst Forecast & Price Prediction
Start investing in AMN
Order type
Buy in
Order amount
Est. shares
0 shares